Durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH 303)

Authors
Category Primary study
ConferenceMovement Disorders
Year 2012
This article has no abstract
Epistemonikos ID: c0c7aa87d50b07fd230fba9603f81eb0a6dc7dee
First added on: Apr 30, 2026